Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol

The European Journal of Neuroscience
M SolinasS R Goldberg

Abstract

beta-Endorphin is an endogenous opioid that produces behavioral effects similar to heroin and morphine and is released in the nucleus accumbens by cocaine, amphetamine and ethanol, suggesting a general involvement in the reinforcing effects of abused drugs. Here we show that, in rats, Delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, produces large increases in extracellular levels of beta-endorphin in the ventral tegmental area and lesser increases in the shell of the nucleus accumbens. We then used a two-lever choice THC-discrimination procedure to investigate whether THC-induced changes in endogenous levels of beta-endorphin regulate the discriminative effects of THC. In rats that had learned to discriminate injections of THC from injections of vehicle, the opioid agonist morphine did not produce THC-like discriminative effects but markedly potentiated discrimination of THC. Conversely, the opioid antagonist naloxone reduced the discriminative effects of THC. Bilateral microinjections of beta-endorphin directly into the ventral tegmental area, but not into the shell of the nucleus accumbens, markedly potentiated the discriminative effects of ineffective threshold doses of THC but had no effect...Continue Reading

References

Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·E L Gardner, J H Lowinson
Feb 1, 1985·Drug and Alcohol Dependence·S G Holtzman
Aug 1, 1981·Journal of Clinical Pharmacology·R G Browne, A Weissman
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L StinusM Le Moal
Jan 22, 1993·The Journal of Comparative Neurology·L A MatsudaS J Lolait
Mar 22, 1996·Annals of the New York Academy of Sciences·T ReisineM Tallent
Jan 1, 1997·Psychopharmacology·A Herz
Jan 27, 1998·Pharmacology, Biochemistry, and Behavior·A BecharaD van der Kooy
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·J L Wiley
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·F C Colpaert
May 17, 2000·Drug and Alcohol Dependence·S R Wachtel, H de Wit
Oct 18, 2000·European Journal of Pharmacology·J M Van ReeC L Van den Berg
Oct 21, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·M MelisM Diana
Jun 8, 2001·Reviews in the Neurosciences·L Pulvirenti, M Diana
Aug 17, 2002·Pharmacology & Therapeutics·Rafael Maldonado
Aug 20, 2002·Psychopharmacology·Fernando Berrendero, Rafael Maldonado
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Allyn C Howlett
Dec 20, 2002·Psychopharmacology·Margaret HaneyRichard W Foltin
Jan 22, 2003·The European Journal of Neuroscience·Anna CastañéRafael Maldonado
Apr 2, 2003·Nature Reviews. Drug Discovery·Francis C Colpaert
Nov 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rafael Maldonado, Olga Valverde

❮ Previous
Next ❯

Citations

May 22, 2010·Psychopharmacology·Ziva D Cooper, Margaret Haney
Apr 7, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marcello Solinas, Steven R Goldberg
Sep 9, 2005·Behavioural Pharmacology·T C Kirkham
Jun 27, 2006·The AAPS Journal·Yanjun LiHartmut Derendorf
Feb 13, 2014·Translational Psychiatry·F J MeyeR A H Adan
Dec 3, 2014·Acta Neuropsychiatrica·Livia C M RodriguesAlline Cristina Campos
Apr 16, 2009·International Review of Psychiatry·Tim C Kirkham
Mar 24, 2009·Alcoholism, Clinical and Experimental Research·Samuel JarjourChristina Gianoulakis
Sep 19, 2012·Journal of Pharmacological Sciences·Tomohisa MoriTsutomu Suzuki
Jul 8, 2008·Progress in Neurobiology·Ilana Roth-DeriGal Yadid
Jul 26, 2005·Peptides·Richard J Bodnar, Gad E Klein
Apr 5, 2017·Neuropharmacology·Miriam MelisDaniela Parolaro
Aug 29, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Leigh V Panlilio, Zuzana Justinova
Nov 9, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret Haney
May 5, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marcello SolinasSteven R Goldberg
Jul 11, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maria EllgrenYasmin L Hurd
Sep 30, 2005·Addiction Biology·Derik HermannBernhard Croissant
Mar 14, 2007·The Journal of Pharmacology and Experimental Therapeutics·Marcello SolinasSteven R Goldberg
Nov 5, 2004·The Journal of Pharmacology and Experimental Therapeutics·Bernard Le Foll, Steven R Goldberg
Mar 20, 2015·Clinical Pharmacology and Therapeutics·L V PanlilioZ Justinova
Dec 23, 2020·Journal of Neuroscience Research·Aida Mohammadkhani, Stephanie L Borgland
Nov 11, 2020·Neuroscience and Biobehavioral Reviews·Salar VaseghiMohammad-Reza Zarrindast
Apr 24, 2021·Journal of Neurochemistry·Andrew J Kesner, David M Lovinger
Aug 29, 2021·Translational Psychiatry·Tatu KantonenLauri Nummenmaa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.